Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Halabi, Susan"'
Autor:
Aggarwal, Rahul, Halabi, Susan, Kelly, William Kevin, George, Daniel, Mahoney, John F, Millard, Frederick, Stadler, Walter M, Morris, Michael J, Kantoff, Philip, Monk, J Paul, Carducci, Michael, Small, Eric J, Alliance for Clinical Trials in Oncology
Publikováno v:
Cancer, vol 119, iss 20
BackgroundPreliminary data suggest a potential decreased benefit of docetaxel in patients with metastatic, castration-resistant prostate cancer (mCRPC) who previously received abiraterone acetate, a novel androgen synthesis inhibitor (ASI). Cancer an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::af0fe86e457be39148c2f3d5cf9a6e82
https://escholarship.org/uc/item/28d6p66f
https://escholarship.org/uc/item/28d6p66f
Autor:
Aggarwal, Rahul, Halabi, Susan, Kelly, William Kevin, George, Daniel, Mahoney, John F., Millard, Frederick, Stadler, Walter M., Morris, Michael J., Kantoff, Philip, Monk, J. Paul, Carducci, Michael, Small, Eric J.
Preliminary data suggest a potential decreased benefit of docetaxel in patients with metastatic, castration-resistant prostate cancer (mCRPC) who previously received abiraterone acetate, a novel androgen synthesis inhibitor (ASI). Cancer and Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fe2980224bd5b187489daf345a5f9883
https://europepmc.org/articles/PMC3795898/
https://europepmc.org/articles/PMC3795898/